may make it a more appropriate agent for testing the vasodilator response. Background -In patients with primary (Thorax 1997;52:369-372) pulmonary hypertension who respond to vasodilators acutely, survival can be im- Keywords: pulmonary hypertension, vasodilators, nitric proved by the long term use of calcium oxide, prostacyclin, calcium channel blockers.
PGI 2 =prostacyclin; PAP and PVR=change in mean pulmonary artery pressure and pulmonary vascular resistance induced by the agent; +=responder; −= non-responder. * Dose required to obtain a significant effect in responders and maximal administered dose in non-responders. For definition of response, see text.
venous blood samples were collected sim-ues of PAPspont for the responders were compared with those of the decrease in mean ultaneously for blood gas determinations. Derived variables were computed according to PAP obtained with each vasodilator using a Wilcoxon signed rank test. standard equations.
Since a previous study from our ICU demonstrated a 24 hour variability of 11% in mean PAP and 14% in pulmonary vascular resistance Results
All results are expressed as mean (SD). Ten (PVR) in patients with pulmonary hypertension, in the absence of any drug ad-patients were studied, four of whom had primary pulmonary hypertension while in the others ministration, 7 these parameters were first recorded every hour for 24 hours without any pulmonary hypertension was associated with cirrhosis and portal hypertension (2), conpharmacological intervention. The mean 24 hour variability was defined as the coefficient nective tissue disease (2), thromboembolic disease (1), and HIV infection (1). All had severe of variation of these measurements. NO was administered at inhaled concentrations of 10, pulmonary hypertension (mean PAP 49 (13) mm Hg, PVR 974 (573) dyn.s.cm −5 ), and eight 20, and 40 ppm, each for 15 minutes, using a previously described technique.
8 Inhaled NO had a low cardiac index (1.9 (0.5) l/min/m 2 ) and increased systemic vascular resistance (SVR) and NO 2 concentrations were monitored online by an electrochemical device (Polytron, (2227 (852) dyn.s.cm −5 ). The mean 24 hour variability in the mean PAP and PVR was 11 Dräger AG, Lü beck, Germany). After a one hour period to allow a return to baseline con-(3)% and 13 (5)%, respectively. All patients except patient 1 were moderately hypoxaemic ditions, a continuous infusion of prostacyclin (PGI 2 , Flolan, Wellcome Research Laboratory, (Pa 2 8.9 (1.2) kPa) and had increased Q/ Q (18 (8)%). Three patients (nos 4, 6, and Beckenham, UK) was started at an initial rate of 1 ng/kg/min, and increased by 1 ng/kg/min 8) were receiving supplemental oxygen.
There was no difference between baseline increments every 10 minutes up to a maximum of 10 ng/kg/min. Measurements were made values before administration of the three agents, except for a small but significant difference in when a response was obtained, side effects appeared, or if there was no response after 10 heart rate between NO and PGI 2 (80 (13) beats/min before NO and 73 (9) beats/min minutes at the maximum dosage. The following day patients received a loading dose of 10 mg before PGI 2 ). The individual responses to the three vasodilators are indicated in table 1, tonifedipine orally followed by 20 mg every hour. If the mean systemic arterial pressure was gether with the dose of the agent required to obtain that effect. Six patients responded to all 75 mm Hg or less the loading dose was reduced to 5 mg and subsequent doses to 10 mg. three agents (60%) while three responded to none (30% , conditions such as hepatic cirrhosis, collagen disease, and HIV infection, which were present p<0.002). Pa 2 was lowered by PGI 2 (8.7 (1.4) versus 10.8 (1) kPa, p<0.01) and nifedipine in some of our patients, are often closely associated with primary pulmonary hyper-(8.6 (1.4) versus 10.2 (1.5) kPa, p<0.01). Q/ Q was markedly increased with PGI 2 and tension.
10 Secondly, the criteria we chose as a positive response to a given vasodilator were nifedipine in all patients, whereas with NO there was no significant variation for the group, decreases of 20% or more in mean PAP or PVR, in line with a study by Weir et al. 9 Other even though Q/Q did increase in three patients (fig 1) . studies have relied on different response criteria such as a reduction in PVR of 50% and of In responders the decrease in mean PAP with each vasodilator was significantly different from mean PAP by 33%, 11 a [20% decrease in mean PAP and PVR, 1 or a 30% decrease in total spontaneous variability ( PAPspont 12 (5)% versus 23 (10)% with NO, 17 (7)% with PGI 2 , pulmonary resistance. 4 Thirdly, the duration of pulmonary hypertension before testing might and 20 (9)% with nifedipine, p<0.05).
NO inhalation was well tolerated in all have an influence on reversibility. However, this factor is difficult to account for as inpatients. With PGI 2 patients 3 (non-responder), 4 and 6 (responders) complained of moderate formation on the time from onset of pulmonary hypertension in these patients was not available. chest tightness, slight throbbing headache, and a flushing sensation. Nifedipine induced PGI 2 caused a substantial reduction in SVR which was accompanied by a lowering of SAP hypotension with nausea and lightheadedness in patients 1 (responder), 3 and 9 (non-and a rise in heart rate and cardiac index, effects consistent with the known properties of responders), and hypoxaemia in patients 8 and 9 (non-responders).
the drug. 12 While NO had no effect on gas exchange, PGI 2 produced a considerable increase in Q/Q (fig 1) , as well as a concomitant fall in Pa 2 . This could result from Discussion This study confirms that NO inhalation can increased blood flow to low ventilation-perfusion pulmonary zones by attenuating hypoxic accurately predict the response to nifedipine without adverse consequences. In contrast, vasoconstriction 13 or a rise in cardiac index.
14 Finally, PGI 2 and nifedipine had comparable PGI 2 induced a substantial lowering of SVR and SAP, accompanied by a rise in cardiac effects on haemodynamics and gas exchange.
In conclusion, this study supports the exindex and heart rate as well as an absence of decrease in PAP and a marked increase in Q/ isting preliminary data that, with a predictive ability at least as good or perhaps better than Q.
These results confirm those of recent studies PGI 2 , NO could be a valid alternative to PGI 2 in testing for preserved pulmonary vasoby Sitbon et al 4 and Cockrill et al, 5 with the exception that the overall response rate of 60% reactivity in patients with severe precapillary pulmonary hypertension. to vasodilators is higher than the rates of 37% and 50% obtained in these studies. The drug dosage used in our study is consistent with the 1 Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulstandardised protocols used in most studies. geneous nature of our study group must be Conclusion -Induced sputum is rich in Safety issues and access to expert reneutrophils and eosinophils and poor in sources limit this technique as a research lymphocytes, suggesting an origin in the tool. Induced sputum is a non-invasive larger airways. Induced sputum ademethod of collecting airway fluid which quately reflects the findings in fluid colis applicable to subjects with a range of lected by direct bronchoscopy. severity of airflow obstruction. The (Thorax 1997; 52:372-374) method of sputum collection and processing differs between groups. A study was undertaken to compare induced Keywords: induced sputum, bronchial washings, differential cell counts. sputum with bronchoscopically collected fluid. Methods -Sixteen patients with mild Airway inflammation is a characteristic feature stable asthma underwent both sputum in-of asthma. The use of bronchoalveolar lavage duction and bronchoscopic examination (BAL) and bronchial biopsy has provided a with bronchial washings and broncho-greater understanding of the pathogenesis of alveolar lavage (BAL) in random order, this disease. 1 The application of these techwith each procedure being separated by niques has helped to define, not only the inan interval of 12 days. Airway fluid was flammatory cell population, but also the National Heart and processed and stained for differential cell presence of inflammatory mediators and cyto- chial washing in terms of differential cell counts and have found these to correlate. 7 We report the findings of a similar study using a modified method of sputum collection and processing.
Bronchoscopic examination
Each subject inhaled 200 g salbutamol 30 minutes before the bronchoscopic exMethods  amination. The bronchoscope (Key Med Ltd, Southend, Essex) was introduced via the nose Sixteen subjects (12 men) with stable asthma, of mean (SE) age 25.3 (3.1) years and forced following application of the local anaesthetic lignocaine 4% and sedation with intravenous expiratory volume in one second (FEV 1 ) 95.6 (4.1)% predicted, were recruited. All were tak-midazolam in a dose of 5-10 mg. The bronchoscope was wedged in the right middle lobe, ing inhaled 2 agonists only and subjects who had a respiratory tract infection or exacerbation 60 ml of warmed normal saline was instilled, and the aspirate was collected and labelled as of asthma within the previous eight weeks were excluded. All subjects gave written informed bronchial washing. The next 180 ml saline was instilled and the aspirated fluid labelled as BAL consent and the study was approved by the ethics committee of the Royal Brompton Hos-fluid. pital.
Processing of bronchial washing and BAL fluid samples
Bronchial washing and BAL samples were kept   Each subject underwent a bronchoscopic ex-on ice prior to processing. They were centrifuged at 300g for 10 minutes, the pellet was amination and a sputum induction in random order with an interval of 12 days between each resuspended in Hank's balanced salt solution, and a total cell count was carried out on a procedure.
haemacytometer. Slide preparations were made using a cytospin and stained as for the induced sputum slides. Sputum induction and processing Subjects inhaled 200 g salbutamol via a metered dose inhaler 10 minutes before the   Total and differential cell counts were comsputum induction. Each subject mouthwashed thoroughly with water before inhaling 3.5% pared using Pearson's rank correlation coefficient. A p value of <0.05 was considered saline nebulised via an ultrasonic nebuliser (DeVilbiss 99, Heston, UK) for a mean dur-significant. ation of 15 (6) minutes. Subjects were encouraged to cough deeply after five minutes and at three minute intervals thereafter. The Results All subjects produced an adequate specimen sputum induction was terminated when at least 1 ml of sputum had been collected; the mean of sputum (defined as at least 1 ml of sputum with <50% squamous epithelial cells on differduration of the procedure was 25 minutes. Sputum was coughed into a polypropylene pot ential cell counting). Nine subjects underwent bronchoscopic examination before sputum inand all saliva was discarded separately.
The volumes of the samples were recorded. duction. Two of these were withdrawn from the study as they developed a cough productive The sample was diluted with 2 ml Hank's balanced salt solution (HBSS) containing 1% di-of sputum following bronchoscopy. FEV 1 was 3.82 (0.20) l, 4.14 (0.21) l, and 3.84 (0.26) l thiothreitol (DTT) (Sigma Chemicals, Poole, UK) and gently vortexed at room temperature. at baseline, following salbutamol, and following sputum induction, respectively. When homogeneous, samples were further diluted with HBSS and centrifuged at 300g for 10 minutes and the cell pellet was resuspended. Total cell counting was carried out on a haema-   The differential cell counts are shown in table cytometer using Kimura stain and slides were made using a cytospin (Shandon, Runcorn, 1. There was a significant correlation between the proportions of neutrophils and eosinophils UK) and stained with May-Grunwald-Giemsa stain for differential cell counts which were in induced sputum and bronchial washings (r= 0.6 and 0.7 for neutrophils and eosinophils, carried out by a blinded observer. Differential cell counts were expressed as percentage of respectively, p<0.05; fig 1) . The relationship between cell profiles in induced sputum and immunocompetent cells -that is, excluding squamous epithelial cells.
BAL fluid was not, however, significant.
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Induced sputum is richer in eosinophils and neutrophils and poorer in lymphocytes and macrophages than bronchial washings or BAL fluid. The proportions of neutrophils and eosinophils decreased whereas the proportions of lymphocytes and macrophages increased progressively from induced sputum to bronchial washing and BAL fluid. It has previously been shown that neutrophils and eosinophils are increased whilst macrophages and lymphocytes are reduced in bronchial washings compared with BAL fluid. 9 The finding of high percentages of neutrophils and eosinophils in induced sputum suggests that this fluid originates in the more proximal bronchi or may be a result of the relative ease by which different cell types are cleared using lavage and sputum induction. Alternatively, these findings could be a response to hypertonic saline inhalation. This is unlikely as differential cell counts in induced sputum do not differ from those in spontaneously produced sputum.
10
Sputum induction is a non-invasive technique that was tolerated well by all the subjects and there were no adverse effects. As sputum induction is a simple inexpensive procedure we consider that it could be used as a routine tool in clinical studies of asthma, allowing information on the anti-inflammatory effects of drugs to be assessed and the course of inflammatory disease in the airways and the effects of intervention to be monitored. Its simple non-invasive nature may facilitate recruitment into such studies. We have confirmed that sputum induction al- 
